Da? Duh!

  • by: |
  • 08/07/2006

And you thought we were in denial when it comes to dealing with counterfeit prescription medicines.

Check this out —

In Moscow, Duma Speaker Boris Gryzlov stressed the need to “ban the flow of medicines into retail without using technologies that protect medicines from counterfeiting.” Speaking during a meeting of United Russia Duma deputies and President Vladimir Putin, Gryzlov said legislators would clean up the pharmaceuticals market in the fall.

Get that? Legislators will get it done without technology.

Rooting out counterfeit medicines is “absolutely not a matter of technology,” said Veniamin Monblit, research director at Comcon, a research company.

Absolutely not a matter of technology? That’s some research company.

“The equipment for manufacturing medicine is expensive and complex. It cannot be installed at a dacha or in some shed,” Monblit said.

Oh really? Would you like to see some pictures?

In Russia, according to Monblit, counterfeit medicines are sometimes produced at the same plants that make legal medicines. “It’s a matter of catching them and closing them down,” he said.

Thanks for the clarification.

According to the Moscow Times, the making or selling counterfeit medicines is not currently considered a criminal offense under the law.

Note to Gryzlov and Monblit — your copies of “Coincidence or Crisis” are on the way, courtesy of the Center for Medicine in the Public Interest.

(Comrades, you can also download the book at www.cmpi.org — but that would require using … technology.)

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog